Chase AIPricingFAQs
Display currency
Loading news…

Athera Biotechnologies

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Stockholm, Stockholms Lan, Sweden Founded 2005 1-10 employees For Profit

Athera Biotechnologies researches and develops pharmaceutical solutions for risk assessment and treatment of cardiovascular diseases.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
1
Patents
11
1 trademarks

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
2
Patents granted
11
Trademarks
1
Top patent class
Medical Or Veterinary Science; Hygiene
IT spend
$614K

Company Info

Founded
2005
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
News articles
3
HQ
Stockholm, Stockholms Lan, Sweden
Region
European Union (EU), Nordic Countries, Scandinavia

Signals & Scores

Heat score
Medium
Growth score
Low
Trend (7d)
0
Trend (30d)
1.2
Trend (90d)
0.4
1
professional contacts at Athera Biotechnologies
Contact execs at Athera Biotechnologies

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Athera Biotechnologies

Loading news…

FAQs about Athera Biotechnologies

People who checked this page also checked these

Browse the full Acquirezy directory.
Athera Biotechnologies - Company Profile, Full Acquisitions List, Funding and Investments